Proteomic research progress in lymphatic metastases of cancers

Clinical and Translational Oncology

Volumn 14, Issue 1, 2012, Pages 21-30

  Zong, Junwei ^a   Guo, Chunmei ^a   Liu, Shuqing ^a   Sun, Ming Zhong ^a   Tang, Jianwu ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Cancer; Lymphatic metastasis; Proteomics

Indexed keywords

ACTIN; ANNEXIN; CYTOKERATIN 10; CYTOKERATIN 19; CYTOSKELETON PROTEIN; DESMIN; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; PERIPLAKIN; PROTEIN DISULFIDE ISOMERASE; RAF PROTEIN; TROPOMYOSIN;

BREAST CANCER; CANCER GROWTH; CANCER PROGNOSIS; COLORECTAL CANCER; ESOPHAGUS CANCER; GENE PRODUCT; HUMAN; IMMUNOHISTOCHEMISTRY; LIQUID CHROMATOGRAPHY; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MASS SPECTROMETRY; NASOPHARYNX CANCER; NONHUMAN; PROTEIN FUNCTION; PROTEOMICS; RAT; REVIEW; STOMACH CANCER; TISSUE MICROARRAY; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANIMALS; HUMANS; LYMPHATIC METASTASIS; NEOPLASMS; PROTEOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84860732211     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-012-0757-7     Document Type: Review

References (79)

1. Yokota J (2000) Tumor progression and metastasis. Carcinogenesis 21:497-503 (Pubitemid 30137935)
2. Liu S, Sun MZ, Tang JW et al (2008) Highperformance liquid chromatography/nano-elec-trospray ionization tandem mass spectrometry, two-dimensional difference in-gel electrophoresis and gene microarray identification of lymphatic metastasis-associated biomarkers. Rapid Commun Mass Spectrom 22:3172-3178
3. Pepper M (2001) Lymphangiogenesis and tumor metastasis. Clin Cancer Res 7:462-468
4. Wang C, Lin K, Chen S et al (2004) Overexpres-sion of SPARC gene in human gastric carcinoma and its clinicopathologic significance. Br J Cancer 91:1924-1930 (Pubitemid 40065522)
5. Parkin DM, Bray F, Ferlay J et al (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108 (Pubitemid 40372904)
6. Llovet JM, Burroughs A, Bruix J (2003) Hepato-cellular carcinoma. Lancet 362:1907-1917
7. Hou L, Li Y, Jia YH et al (2001) Molecular mechanism about lymphogenous metastasis of hepa-tocarcinoma cells in mice. World J Gastroenterol 7:532-536 (Pubitemid 32780665)
8. Sun MZ, Liu S, Tang J et al (2009) Proteomics analysis of two mice hepatocarcinoma ascites syngeneic cell lines with high and low lymph node metastasis rates provide potential protein markers for tumor malignancy attributes to lymphatic metastasis. Proteomics 9:3285-3302
9. Miyoshi Y, Nakayama S, Torikoshi Y et al (2006) High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early re-currence in patients with invasive breast cancer. Cancer Sci 97:523-529 (Pubitemid 43811594)
10. Myung JK, Afjehi-Sadat L, Felizardo-Cabatic M et al (2004) Expressional patterns of chaperones in ten human tumor cell lines. Proteome Sci 2:8
11. Chen N, Sun W, Deng X et al (2008) Quantitative proteome analysis of HCC cell lines with different metastatic potentials by SILAC. Proteomics 8:5108-5118
12. Luu-The V, Tremblay P, Labrie F (2006) Characterization of type 12 17beta-hydroxysteroid dehy-drogenase, an isoform of type 3 17beta-hydrox- ysteroid dehydrogenase responsible for estradiol formation in women. Mol Endocrinol 20:437-443 (Pubitemid 43152516)
13. Jansson A, Carlsson J, Olsson A et al (2007) A new polymorphism in the coding region of exon four in HSD17B2 in relation to risk of sporadic and hereditary breast cancer. Breast Cancer Res Treat 106:57-64 (Pubitemid 47498094)
14. Panet R, Marcus Matlan H (2000) Overexpres-sion of the Na(+)/K(+)/Cl(-) cotransporter gene induces cell proliferation and phenotypic transformation in mouse fibroblasts. J Cell Physiol 182: 109-118 (Pubitemid 129710505)
15. Gumireddy K, Sun F, Klein-Szanto AJ et al (2007) In vivo selection for metastasis promoting genes in the mouse. Proc Natl Acad Sci U S A 104: 6696-6701 (Pubitemid 47175563)
16. Yang XR, Xu Y, Shi GM et al (2008) Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection. Clin Cancer Res 14:3850-3859
17. Hsu YC, Fu HH, Jeng YM et al (2006) Proline-directed protein kinase FA is a powerful and independent prognostic predictor for progression and patient survival of hepatocellular carcinoma. J Clin Oncol 24:3780-3788
18. Park JH, Koh KC, Choi MS et al (2006) Analysis of risk factors associated with early multinodular recurrences after hepatic resection for hepatocel-lular carcinoma. Am J Surg 192:29-33 (Pubitemid 43849602)
19. Zhuang PY, Zhang JB, Zhu XD et al (2008) Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor. Cancer 112:2740-2748
20. Corcelle V, Stieger B, Gjinovci A et al (2006) Characterization of two distinct liver progenitor cell subpopulations of hematopoietic and hepatic origins. Exp Cell Res 312:2826-2836
21. Roskams T (2006) Liver stem cells and their implication in hepatocellular and cholangiocarci-noma. Oncogene 25:3818-3822 (Pubitemid 43980477)
22. Yi X, Luk JM, Lee NP et al (2008) Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. Mol Cell Proteomics 7:315-325 (Pubitemid 351298446)
23. Dai Z, Zhou J, Li X-F et al (2007) An analysis of annexin II related to HCC metastatic ability. Chin J Hepatol 15:563-566
24. Guo K, Liu Y, Zhou H et al (2008) Involvement of protein kinase C beta-extracellular signal-regulating kinase 1/2/p38 mitogen-activated protein kinase-heat shock protein 27 activation in hepa-tocellular carcinoma cell motility and invasion. Cancer Sci 99:486-496 (Pubitemid 351228564)
25. Li L, Chen SH, Yu CH et al (2008) Identification of hepatocellular- carcinoma-associated antigens and autoantibodies by serological proteome analysis combined with protein microarray. J Proteome Res 7:611-620 (Pubitemid 351294023)
26. Lee NP, Leung KW, Cheung N et al (2008) Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocellular carcinoma. Proteomics 8:2136-2149 (Pubitemid 351775792)
27. Liu LX, Lee NP, Chan VW et al (2009) Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma. Hepatology 50: 1453-1463
28. Chen J, Kahne T, Rocken C et al (2004) Proteome analysis of gastric cancer metastasis by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of metastasis-related proteins. J Proteome Res 3:1009-1016 (Pubitemid 39425658)
29. Concannon CG, Gorman AM, Samali A (2003) On the role of Hsp27 in regulating apoptosis. Apoptosis 8:61-70 (Pubitemid 36133139)
30. Pei H, Zhu H, Zeng S et al (2007) Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer. J Proteome Res 6:2495-2501 (Pubitemid 47122346)
31. Tian T, Hao J, Xu A et al (2007) Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis. Cancer Sci 98:1265-1274 (Pubitemid 46993548)
32. Babbin BA, Lee WY, Parkos CA et al (2006) Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J Biol Chem 281:19588-19599 (Pubitemid 44035462)
33. Yao H, Zhang ZX, Chen Y et al (2009) Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection. Lung Cancer 65:41-48
34. Dawling S, Roodi N, Mernaugh RL et al (2001) Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Cancer Res 61:6716-6722 (Pubitemid 32896493)
35. Chen CD, Wang CS, Huang YH et al (2007) Over-expression of CLIC1 in human gastric carcinoma and its clinicopathological significance. Proteom-ics 7:155-167
36. Valenzuela SM, Mazzanti M, Tonini R et al (2000) The nuclear chloride ion channel NCC27 is involved in regulation of the cell cycle. J Physiol 529:541-552 (Pubitemid 32051060)
37. Huang JS, Chao CC, Su TL et al (2004) Diverse cellular transformation capability of overex-pressed genes in human hepatocellular carcinoma. Biochem Biophys Res Commun 315: 950-958
38. Hatakeyama H, Kondo T, Fujii K et al (2006) Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancer. Proteomics 6:6300-6316 (Pubitemid 44935516)
39. Moumen A, Masterson P, O'Connor MJ et al (2005) hnRNP K: an HDM2 target and transcriptional coactivator of p53 in response to DNA damage. Cell 123:1065-1078 (Pubitemid 41785421)
40. Mandal M, Vadlamudi R, Nguyen D et al (2001) Growth factors regulate heterogeneous nuclear ri-bonucleoprotein K expression and function. J Biol Chem 276:9699-9704
41. Ueno T, Tangoku A, Yoshino S et al (2002) Gain of 5p15 detected by comparative genomic hybridization as an independent marker of poor prognosis in patients with esophageal squamous cell carcinoma. Clin Cancer Res 8:526-533 (Pubitemid 34193973)
42. Yasumatsu R, Nakashima T, Hirakawa N et al (2001) Maspin expression in stage I and II oral tongue squamous cell carcinoma. Head Neck 23: 962-966 (Pubitemid 32977539)
43. Nishimori T, Tomonaga T, Matsushita K et al (2006) Proteomic analysis of primary esophageal squamous cell carcinoma reveals downregulation of a cell adhesion protein, periplakin. Proteomics 6:1011-1018 (Pubitemid 43260225)
44. Mandelker DL, Yamashita K, Tokumaru Y et al (2005) PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma. Cancer Res 65:4963-4968 (Pubitemid 40740837)
45. Liu Y, Fallon L, Lashuel HA et al (2002) The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell 112:209-218 (Pubitemid 35292441)
46. Harada T, Harada C, Wang YL et al (2004) Role of ubiquitin carboxy terminal hydrolase-L1 in neural cell apoptosis induced by ischemic retinal injury in vivo. Am J Pathol 164:59-64 (Pubitemid 38364590)
47. Honda K, Yamada T, Hayashida Y et al (2005) Actinin-4 increases cell motility and promotes lymph node metastasis of colorectal cancer. Gas-troenterology 128:51-62 (Pubitemid 40039958)
48. Miyanishi K, Takayama T, Ohi M et al (2001) Glutathione S-transferase-pi overexpression is closely associated with K-ras mutation during human colon carcinogenesis. Gastroenterology 121: 865-874 (Pubitemid 32959396)
49. Guzman-Aranguez A, Olmo N, Turnay J et al (2005) Differentiation of human colon adenocar-cinoma cells alters the expression and intracellu-lar localization of annexins A1, A2, and A5. J Cell Biochem 94:178-193 (Pubitemid 41420335)
50. Lawrie LC, Dundas SR, Curran S et al (2004) Liver fatty acid binding protein expression in col-orectal neoplasia. Br J Cancer 90:1955-1960 (Pubitemid 38746336)
51. Lyall MS, Dundas SR, Curran S et al (2006) Profiling markers of prognosis in colorectal cancer. Clin Cancer Res 12:1184-1191 (Pubitemid 43342507)
52. Ma Y, Zhao M, Zhong J et al (2010) Proteomic profiling of proteins associated with lymph node metastasis in colorectal cancer. J Cell Biochem 110:1512-1519
53. Kim HJ, Kim YM, Lim S et al (2009) Ubiquitin C-terminal hydrolase-L1 is a key regulator of tumor cell invasion and metastasis. Oncogene 28: 117-127
54. Brookes MJ, Hughes S, Turner FE et al (2006) Modulation of iron transport proteins in human colorectal carcinogenesis. Gut 55:1449-1460 (Pubitemid 44476791)
55. Hu X, Zhang Y, Zhang A et al (2009) Comparative serum proteome analysis of human lymph node negative/positive invasive ductal carcinoma of the breast and benign breast disease controls via label-free semiquantitative shotgun technology. OMICS 13:291-300
56. Levy P, Ripoche H, Laurendeau I et al (2007) Microarray-based identification of tenascin C and tenascin XB, genes possibly involved in tumori-genesis associated with neurofibromatosis type 1. Clin Cancer Res 13:398-407 (Pubitemid 46225342)
57. Matsumoto K, Takayama N, Ohnishi J et al (2001) Tumour invasion and metastasis are promoted in mice deficient in tenascin-X. Genes Cells 6:1101-1111 (Pubitemid 33133698)
58. Hagan S, Al-Mulla F, Mallon E et al (2005) Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis. Clin Cancer Res 11:7392-7397 (Pubitemid 41507699)
59. Reddy KB, Nabha SM, Atanaskova N (2003) Role of MAP kinase in tumor progression and invasion. Cancer Metastasis Rev 22:395-403 (Pubitemid 36791895)
60. Yeung KC, Rose DW, Dhillon AS et al (2001) Raf kinase inhibitor protein interacts with NF-kap-paB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Mol Cell Biol 21:7207-7217 (Pubitemid 32953475)
61. Chatterjee D, Bai Y, Wang Z et al (2004) RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. J Biol Chem 279:17515-17523 (Pubitemid 38560515)
62. Sun B, Zhang S, Zhang D et al (2008) Identification of metastasis-related proteins and their clinical relevance to triple-negative human breast cancer. Clin Cancer Res 14:7050-7059
63. Kluger HM, Chelouche Lev D, Kluger Y et al (2005) Using a xenograft model of human breast cancer metastasis to find genes associated with clinically aggressive disease. Cancer Res 65: 5578-5587 (Pubitemid 40911158)
64. Kallergi G, Mavroudis D, Georgoulias V et al (2007) Phosphorylation of FAK, PI-3K, and impaired actin organization in CK-positive micro-metastatic breast cancer cells. Mol Med 13:79-88 (Pubitemid 46786836)
65. Heizmann CW, Fritz G, Schafer BW (2002) S100 proteins: structure, functions and pathology. Front Biosci 2:d1356-1368
66. Mori M, Shimada H, Gunji Y et al (2004) S100A11 gene identified by in-house cDNA mi-croarray as an accurate predictor of lymph node metastases of gastric cancer. Oncol Rep 11:1287-1295
67. Song HY, Liu YK, Feng JT et al (2006) Proteomic analysis on metastasis-associated proteins of human hepatocellular carcinoma tissues. J Cancer Res Clin Oncol 132:92-98
68. Liu YF, Xiao ZQ, Li MX et al (2009) Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma. J Pathol 217:54-64
69. Wu W, Tang X, Hu W et al (2002) Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry. Clin Exp Metastasis 19:319-326 (Pubitemid 34606757)
70. Chan CM, Wong SC, Lam MY et al (2008) Pro-teomic comparison of nasopharyngeal cancer cell lines C666-1 and NP69 identifies down-regulation of annexin II and beta2-tubulin for nasopharynge-al carcinoma. Arch Pathol Lab Med 132:675-683 (Pubitemid 351489621)
71. Park JE, Lee DH, Lee JA et al (2005) Annexin A3 is a potential angiogenic mediator. Biochem Biophys Res Commun 337:1283-1287 (Pubitemid 41505261)
72. Li DJ, Deng G, Xiao ZQ et al (2009) Identificat-ing 14-3-3 sigma as a lymph node metastasis-related protein in human lung squamous carcinoma. Cancer Lett 279:65-73
73. Lehnigk U, Zimmermann U, Woenckhaus C et al (2005) Localization of annexins I, II, IV and VII in whole prostate sections from radical prostatectomy patients. Histol Histopathol 20:673-680 (Pubitemid 40932583)
74. Emoto K, Yamada Y, Sawada H et al (2001) Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma. Cancer 92:1419-1426 (Pubitemid 32947825)
75. Emoto K, Sawada H, Yamada Y et al (2001) Annexin II overexpression is correlated with poor prognosis in human gastric carcinoma. Anticancer Res 21:1339-1345
76. Zhou G, Zhai Y, Cui Y et al (2007) MDM2 promoter SNP309 is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population. Clin Cancer Res 13:2627
77. Cheng L, Zhou L, Tao L et al (2008) SELDI-TOF MS profiling of serum for detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis. J Cancer Res Clin Oncol 134:769-776
78. Liang L, Qu L, Ding Y (2007) Protein and mRNA characterization in human colorectal carcinoma cell lines with different metastatic potentials. Cancer Invest 25:427-434 (Pubitemid 47450672)
79. Wang KL, Wu TT, Resetkova E et al (2006) Expression of annexin A1 in esophageal and esoph-agogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res 12:4598-4604 (Pubitemid 44297810)